| 1 |
33310753 | Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease. | 2021 Jan 27 |
2 |
| 2 |
33516737 | Exposure of R6/2 mice in an enriched environment augments P42 therapy efficacy on Huntington's disease progression. | 2021 Mar 15 |
1 |
| 3 |
34884469 | C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice. | 2021 Nov 23 |
1 |
| 4 |
32574176 | Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease. | 2020 |
1 |
| 5 |
28359739 | 2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington's disease. | 2017 Jul |
1 |
| 6 |
29151587 | Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models. | 2017 Dec |
3 |
| 7 |
26581643 | Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology. | 2016 Jan 30 |
1 |
| 8 |
25057205 | Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex. | 2014 Jul 23 |
1 |
| 9 |
21542802 | Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function. | 2011 Jun 7 |
1 |
| 10 |
20424159 | Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. | 2010 Jul 2 |
1 |
| 11 |
19864571 | Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. | 2009 Oct 28 |
1 |